Business
– RedHill Biopharma and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement for RedHill’s RHB-106 Encapsulated Bowel Preparation. Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) and RedHill Biopharma...
Hi, what are you looking for?
– RedHill Biopharma and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement for RedHill’s RHB-106 Encapsulated Bowel Preparation. Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) and RedHill Biopharma...
– Clal Biotechnology Industries Ltd. (TASE: CBI) has signed a non-binding letter of intent to sell diabetes treatment developer Andromeda Biotech Ltd. to a US pharmaceutical company for...
– Teva will receive $72 million from future sales or from the proceeds of an exit, if any. Diapep277 Slowing the Progression of Type 1...
– – Israeli medical device maker Brainsway Ltd (TASE:BRIN) , has installed its new Deep Transcranial Magnetic Stimulation (dTMS) device for the treatment of depression...
– – PhotoMedex, Inc. (NasdaqGS and TASE: PHMD), a global skin health company, which has been traded on the Tel Aviv Stock Exchange (TASE) it merged...
– Synribo received provisional approval in 2012 subject to additional clinic trial data. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the U.S. Food and Drug...
– Teva earned lower profits on flat revenue for 2013, but beat the analysts’ consensus. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today reported...
– – U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) new dose of COPAXONE drug application (sNDA) for three-times-a-week 40mg/mL....
– Europe’s Committee for Medicinal Products for Human Use: The risk-benefit profile of laquinimod is not favorable at this time. – – Teva Pharmaceutical...
– Bonuses could boost Erez Vigodman’s compensation to $4.1 million annually, not including options. – – The basic salary of incoming Teva Pharmaceutical Industries Ltd. (NYSE:TEVA;...